NATCOPHARM - Technical Analysis with Chart Patterns & Indicators

Last Updated Time : 19 Sept 25, 2:16 pm

Technical Rating: 3.6

Here’s a detailed technical analysis of Natco Pharma Ltd (NATCOPHARM)

📊 Trend Overview

Current Trend: Mildly bearish

Phase: Consolidating with downside bias

Bias: Neutral to negative, with weakening momentum and resistance near key moving averages

📈 Technical Indicators Analysis

🔹 Moving Averages

50 DMA: ₹890

200 DMA: ₹974

Current Price: ₹884

Price is below both DMAs → signals short-term weakness

Downward slope on 200 DMA suggests longer-term bearish pressure

🔹 RSI (Relative Strength Index)

RSI: 53.6

Neutral zone → no overbought/oversold signal

Indicates indecision and lack of strong momentum

🔹 MACD (Moving Average Convergence Divergence)

MACD: -12.7

Negative MACD → confirms bearish momentum

No bullish crossover → trend remains weak

🔹 Bollinger Bands

Price near middle band → consolidation zone

Bands are moderately tight → low volatility

No breakout or squeeze pattern visible

🔹 Volume Trends

Current Volume: 16.9 lakh

1-Week Avg Volume: 6.2 lakh

Volume spike suggests speculative interest

Not backed by strong price action → lacks conviction

📌 Support & Resistance Levels

Level Price (₹) Commentary

Support 1 860 Minor support zone

Support 2 820 Previous swing low

Resistance 1 890 50 DMA, immediate ceiling

Resistance 2 950 Intermediate resistance

Resistance 3 974 200 DMA, major breakout level

🎯 Entry & Exit Zones

Optimal Entry Zone: ₹860–₹875 (on pullback near support)

Exit Zone / Profit Booking: ₹950–₹974 (resistance and breakout target)

🔍 Momentum Signals

Short-Term: Weak momentum, MACD and RSI not confirming strength

Medium-Term: Consolidation likely to continue unless price breaks above ₹890 with volume

Volume: Elevated, but needs directional confirmation

🧭 Conclusion

NATCOPHARM is currently consolidating with bearish undertones. Technical indicators show indecision, and the price is struggling to reclaim the 50 DMA. Traders may consider accumulating near ₹860 with a tight stop-loss, targeting ₹950–₹974 if volume confirms a breakout.

Would you like to compare this setup with other pharma stocks or set alerts for trend reversal signals?

Edit in a page